| Efficacy of a Deep Learning System for Detecting Glaucomatous Optic Neuropathy Based on Color Fundus Photographs |
79 |
| Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT Classification of Atrophy Report 3 |
67 |
| Accuracy of Intraocular Lens Calculation Formulas |
66 |
| Fully Automated Detection and Quantification of Macular Fluid in OCT Using Deep Learning |
56 |
| Low-Concentration Atropine for Myopia Progression (LAMP) Study A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control |
55 |
| Guidelines on Diabetic Eye Care The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings |
52 |
| Polypoidal Choroidal Vasculopathy Definition, Pathogenesis, Diagnosis, and Management |
48 |
| Grader Variability and the Importance of Reference Standards for Evaluating Machine Learning Models for Diabetic Retinopathy |
47 |
| A Deep Learning Algorithm for Prediction of Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration from Color Fundus Photography |
46 |
| Descemet Membrane Endothelial Keratoplasty: Safety and Outcomes A Report by the American Academy of Ophthalmology |
46 |
| Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration Results with Ranibizumab from the TREND Study |
45 |
| Myopia Prevention and Outdoor Light Intensity in a School-Based Cluster Randomized Trial |
44 |
| Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy Results of Phase 1 and 3 Trials |
44 |
| Spectral-Domain OCT Measurements in Alzheimer's Disease A Systematic Review and Meta-analysis |
42 |
| Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia Systematic Review, Meta-analysis, and Modelling |
41 |
| The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration Results from the Randomized Phase 2 Ladder Clinical Trial |
39 |
| The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration |
35 |
| Natural History of Subclinical Neovascularization in Nonexudative Age-Related Macular Degeneration Using Swept-Source OCT Angiography |
35 |
| Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up |
35 |
| A Dosing Study of Bevacizumab for Retinopathy of Prematurity Late Recurrences and Additional Treatments |
33 |
| Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor |
33 |
| Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension |
33 |
| Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen FLUID Study 24-Month Results |
32 |
| Using a Deep Learning Algorithm and Integrated Gradients Explanation to Assist Grading for Diabetic Retinopathy |
31 |
| Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema BOULEVARD Phase 2 Randomized Trial |
31 |
| From Machine to Machine An OCT-Trained Deep Learning Algorithm for Objective Quantification of Glaucomatous Damage in Fundus Photographs |
28 |
| Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract Two-Year Results |
28 |
| A Schlemm Canal Microstent for Intraocular Pressure Reduction in Primary Open-Angle Glaucoma and Cataract The HORIZON Study |
28 |
| Safety and Efficacy of Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration A Report by the American Academy of Ophthalmology |
27 |
| Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration |
27 |
| OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant |
27 |
| Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III |
26 |
| Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis Fundamentals Of Care for UveitiS (FOCUS) Initiative |
26 |
| OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema A Prospective Study |
26 |
| DeepSeeNet: A Deep Learning Model for Automated Classification of Patient-based Age-related Macular Degeneration Severity from Color Fundus Photographs |
26 |
| Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy The PLACE Trial |
26 |
| Peripapillary and Macular Vessel Density in Patients with Primary Open-Angle Glaucoma and Unilateral Visual Field Loss |
25 |
| Progression of Myopic Maculopathy during 18-Year Follow-up |
25 |
| Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration The LEAD Randomized Controlled Clinical Trial |
25 |
| Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium |
24 |
| Five-Year Graft Survival of Descemet Membrane Endothelial Keratoplasty (EK) versus Descemet Stripping EK and the Effect of Donor Sex Matching |
24 |
| Management of Acute Retinal Ischemia Follow the Guidelines! |
23 |
| Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis |
23 |
| Potential Lost Productivity Resulting from the Global Burden of Myopia |
22 |
| Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti-VEGF Drug Type for 1 Year in the IRIS Registry |
21 |
| Descemet Endothelial Thickness Comparison Trial A Randomized Trial Comparing Ultrathin Descemet Stripping Automated Endothelial Keratoplasty with Descemet Membrane Endothelial Keratoplasty |
21 |
| Keratoconus Natural Progression A Systematic Review and Meta-analysis of 11 529 Eyes |
21 |
| Oral Memantine for the Treatment of Glaucoma Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies |
21 |
| Longitudinal Changes of Optic Nerve Head and Peripapillary Structure during Childhood Myopia Progression on OCT Boramae Myopia Cohort Study Report 1 |
20 |
| Measurement Floors and Dynamic Ranges of OCT and OCT Angiography in Glaucoma |
20 |
